CVS Health puts $260K focus on bleeding disorder programs
With March marking Bleeding Disorder Awareness, CVS Health has made $260,000 in charitable commitments to organizations that work with hemophilia and bleeding disorders nationwide. Currently, more than 200,000 people live with hemophilia, making it so their blood does not clot properly, requiring whole blood or platelet transfusions.
“CVS Health recognizes the challenges that come with having a bleeding disorder, and the need for increased research and education,” CVS Health vice president of specialty sales Joel Helle said. “By providing these leading organizations and programs with support, we’re able to help impact the care and quality of life for all people with a bleeding disorder, which advances our company’s purpose of helping people on their path to better health.”
CVS Health has donated $50,000 to the Hemophilia Foundation of America to support education and support for patients with bleeding disorders and their families. It also supports HFA Families, which offers resources to families of patients, as well as Blood Brotherhood, which offers support and education to adult men with blood disorders.
“HFA is pleased to have the support of CVS Health to help raise awareness and to continue the very important advocacy work we do to improve the lives of people in the bleeding disorders community,” HFA president and CEO Kimberly Haugstad said.
The company also is supporting the National Hemophilia Foundation with a $60,000 donation for advocacy, education and research efforts, including its annual awareness effort, the Red Tie Campaign, and its annual walk for hemophilia, UNITE for Bleeding Disorders.
“This collaborative effort is the type of partnership that is necessary to help increase awareness and deliver the programming and support our families desperately need,” said Brett Spitale, vice president of advancement for NHF. “We look forward to growing our partnership with CVS Health in the future allowing us to do more for our community.”
CVS Health’s donations also include more than $150,00 in grants that will go 38 local programs nationwide, each of which is receiving a grant of $1,000 to $7,000 to support local walks, patient retreats and summer camps.
Southeastern Grocers makes bankruptcy declaration official
It’s official — the parent company of grocery banners including Winn-Dixie and Bi-Lo has filed for bankruptcy protection.
Southeastern Grocers filed for Chapter 11 protection on Tuesday, March 27. Following the plan it announced last week, the company is now implementing a “pre-packaged plan of reorganization,” according to Southern Grocers.
The company entered into a restructuring support agreement with a group of creditors and its private equity sponsor regarding a comprehensive financial restructuring that will position the company for long-term financial health. The plan will decrease overall debt levels by over $500 million, enabling the company to maintain a strong liquidity position.
The company will also close 94 stores. However, the supermarket company will continue operating more than 580 stores under the Bi-Lo, Fresco y Más, Harveys Supermarket and Winn-Dixie banners throughout the process.
The slashed debt will reduce interest expenses, allowing the supermarket operator to invest more cash flow back into the business. These will be in the form of increased capital expenditures for store remodels and new stores. The company will also be able to focus its resources on store growth and financial vitality, according to Southern Grocers.
“Today, with the support of our key stakeholders, we are taking the next step in the implementation of our financial restructuring plan,” Anthony Hucker, president and CEO of Southeastern Grocers, said.
“This pre-packaged, court-supervised financial restructuring process provides for a clear and expedited path to put SEG in the best position to serve our communities and succeed in the competitive retail market in which we do business,” Hucker added. “We are extremely pleased that this process continues to proceed quickly and as planned.”
Differentiated offerings key element to WBA growth strategy
With more than half of all prescription drugs today being dispensed to a baby boomer in the U.S., which contributes significantly to an overall U.S. healthcare expenditure equivalent to 18% of the country’s GDP, it has never been more important for pharmacies to deliver on the promise of differentiated offerings.
Rather than chaffe under the pharmacy reimbursement pressures that market dynamic generates, Stefano Pessina, executive vice chairman and CEO Walgreens Boots Alliance, and his team on Wednesday morning pointed to the number of levers Walgreens has to help mitigate escalating healthcare costs and make the retail pharmacy chain a key partner to providers and payers. “Fundamentally we see ourselves as being in very attractive markets,” he said. “The pressures on pharmacy are just elements of the overall pressures on the healthcare system. … It is a sign that everyone recognizes the need to control the inevitable growth in demand [for healthcare services].”
Thanks in part to the differentiated offerings already in play, Walgreens earlier Wednesday morning posted sales of $33 billion for its second quarter ended Feb. 28, an increase of 12.1% from the year-ago quarter, and an increase of 9.4% on a constant currency basis.
Walgreens has both the experience and track record to help manage those healthcare costs.
“The attractiveness of medication-based treatments to keep people leading productive lives in the community continues to increase as the cost of medication remains materially lower than total cost of healthcare,” Pessina said.
Pessina outlined a five-point strategy to capitalize on that growth opportunity:
- Leverage partnerships or acquisitions to consolidate volumes and use these volume efficiencies to buy “best in class” services that are significantly better than the competition;
- Control costs and optimize financial synergies;
- Differentiate services through a combination of exclusive services and innovative own brand offerings;
- Build a portfolio of complementary businesses across a broad geography; and
- Reinvest in the business to drive both organic and external growth.
These efforts have contributed to a commanding prescription market share of 21.4% for the company. That market share is increased 200 basis points over the past three years.
Walgreens is applying similar efforts against developing its front-end business, where gross margins have improved more than 300 base points in the most recent quarter vs. the comparable quarter three years ago.
“This progress has been made through a combination of solid retail management in focusing promotions and applying rigorous financial discipline,” Alex Gourlay, co-COO Walgreens Boots Alliance, said. “Through changes in merchandising and product mix we have furthered our strategy of differentiation and increased penetration of own brands while significantly improving margins. This has been achieved in competitive markets by driving improvements in our health and beauty offerings.”
For example, the Walgreens differentiated beauty offering has been rolled out to approximately 2,900 locations to date, Gourlay reported. “Since we completed the roll out, beauty sales in the beauty differentiation stores have outperformed our non-beauty differentiation stores,” he said. “In the quarter this accounted for a retail margin differential of around 2 percentage points.”
To help deliver a differentiated health offering, Walgreens plans to bring to bear its optical hearing care and lab testing services as part of a new pilot store initiative. “The pilot stores will also provide a platform for the existing initiatives we have already introduced such as our strategic partnership with FedEx,” Gourlay said. “The development of the new store formats and the iterative evolution as we learn more from their performance in the market also provides us with the opportunity to develop a wider range of services and a different value proposition.”
The recent completion of the Rite Aid store acquisitions will help accelerate these front-end growth initiatives, Gourlay added.
Walgreens also has invested $500 million in improving its front-of-store systems and anticipates investing an additional $500 million in the next three years, Gourlay told investors. “We are starting to get good data from our stores and we are making progress toward what we need,” he said. “We are now running the Balance Rewards program as a data and consumer insight tool as much as a marketing program as it was orginally designed.”
That loyalty program today boasts 88.6 million active users, Gourlay said.